Alira Health Published in Business Development & Licensing Journal

Blog April 17, 2023

Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future

When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)

Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)

Blog April 17, 2023

Pharmaceutical Market Access in the UK: A Changing Landscape

Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.

Market Access Pharma UK

Blog April 14, 2023

Lifecycle Optimization: The Path to Commercial Success

Pharmaceutical and biotech companies constantly focus on product innovation. But how can you also increase your effectiveness in order to be as commercially competitive and efficient as possible?

Market Access MedTech Pharma

News April 5, 2023

Alira Health Joins EMIG to Advance Market Access in the UK

We are pleased to announce that Alira Health has joined the Ethical Medicines Industry Group (EMIG), a multi-stakeholder network and trade association that represents the interests(...)

Market Access Patient Centricity UK

Blog March 20, 2023

The State of Market Access in Italy 2023

To learn about the state of market access in Italy today, we spoke with Giovanni Firenze, Director of Market Access Italy for Alira Health, who attended the recent 2023 Conferenza Nazionale(...)

Drug Development Italy Market Access Pharma

Events March 6, 2023

World EPA Congress 2023

We are pleased to share that we will be participating in World EPA Congress 2023 as speakers and sponsors. World Evidence, Pricing and Access Congress is Europe’s largest congress(...)

Biotech Market Access Pharma Real-World Evidence (RWE)

Blog March 6, 2023

Market Access in Catalonia: 2022 Trends and What’s Next

Alira Health contributed to the recently published 2022 BioRegion Report, the most extensive analysis of the assets, achievements, and trends in the life sciences and healthcare sector(...)

Biotech Market Access MedTech Spain